Successful selection of chemotherapy based on cell surface antigens in a patient with mixed phenotype acute leukemia

DOI Web Site 15 References

Bibliographic Information

Other Title
  • 細胞表面抗原に基づく治療方法の選択が奏功した急性混合性白血病
  • 症例報告 細胞表面抗原に基づく治療方法の選択が奏功した急性混合性白血病
  • ショウレイ ホウコク サイボウ ヒョウメン コウゲン ニ モトズク チリョウ ホウホウ ノ センタク ガ ソウコウ シタ キュウセイ コンゴウセイ ハッケツビョウ

Search this article

Abstract

A 47-year-old man was admitted to our hospital in June 2009 because of fatigue and blast cells in peripheral blood. Bone marrow examination showed that 67% leukemic cells were positive for myeloperoxidase (MPO) and negative for esterase stain. Flow cytometric analysis (FCM) revealed the expressions of CD2, cyCD3, CD5, TdT, CD13 on the blasts. Chromosome analysis of the bone marrow cells demonstrated 46, XY in 18 of the 20 analyzed cells, 46,XY,t(1;11)(q21;p15) in 1 of the 20 analyzed cells, and 47,XY,+11 in 1 of the 20 analyzed cells. The patient was diagnosed as having mixed phenotype acute leukemia, T/myeloid, NOS, according to the WHO classification. He received induction chemotherapy for ALL, but could not achieve complete remission (CR). After initial treatment, residual leukemic cells with CD13, CD33 and MPO were detected by FCM; therefore, he received re-induction chemotherapy for AML, and achieved CR. Acute leukemia of ambiguous lineage is a relatively rare subtype in acute leukemia and standard chemotherapy has not been established. It was suggested that the selection of chemotherapy based on the results of FCM was successful in our patient.

Journal

  • Rinsho Ketsueki

    Rinsho Ketsueki 51 (5), 339-344, 2010

    The Japanese Society of Hematology

References(15)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top